Physician profile
Travis P Webb
NPI 1730321894
$2,381.45
in general payments reported to CMS, 2019-2025
12 companies · $65.67 in 2025
The $65.67 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,034 · 2020: $31.76 · 2021: $694 · 2022: $32.74 · 2023: $305 · 2024: $218 · 2025: $65.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,204.31 | 2019-2024 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $573.96 | 2021 | |
| Davol INC. | $299.61 | 2023-2024 | Phasix Mesh |
| Tela Bio, INC. | $120.37 | 2021 | |
| Ethicon US, LLC | $47.63 | 2019-2025 | Stratafix |
| Smith+Nephew, INC. | $29.77 | 2019-2024 | Oasis |
| Aroa Biosurgery Incorporated | $21.69 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.61 | 2025 | Gattex |
| Braintree Laboratories, INC. | $16.72 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.65 | 2020 | |
| Myriad Genetic Laboratories, INC. | $16.02 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $15.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.